FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

ResMed’s stock has surged but faces potential risks from GLP-1 drugs. Find out why RMD stock remains a Hold as investors ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

While sleep supplements can be beneficial, the lack of regulation means consumers are not assured of a safe and effective product.